Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
01 Jun, 2026, 10.11 AM IST
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
01 Jun, 2026, 07.44 AM IST
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
29 May, 2026, 06.01 AM IST
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
28 May, 2026, 09.51 PM IST
Tata Elxsi unveils AnaTel, an AI-powered platform for healthcare software engineering and regulatory complianceTata Elxsi’s AnaTel reflects the growing shift toward AI-native healthcare software engineering, bringing AI-driven automation into regulat...
28 May, 2026, 04.14 PM IST
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
08 May, 2026, 10.19 PM IST
Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
01 May, 2026, 11.26 AM IST
Dr Reddy's signs commercialisation deal with HatchtechDr Reddy's said Hatchtech in September 2014 had announced positive results from its two pivotal phase three clinical studies.
14 Sep, 2015, 12.11 PM IST
KEI Industries rallies as Q1 net more than triplesKEI Industries climbed over 6 per cent in intraday trades after the company said its net profit jumped more than three times.
07 Aug, 2015, 04.03 PM IST
Eveready Industries Q1 Net up nearly 50 per cent at Rs 15.89 croreEveready Industries India Ltd today reported a 49.90 per cent jump in Net profit at Rs 15.89 crore for the first quarter.
24 Jul, 2015, 02.50 PM IST
Opto Circuits rallies as company gets USFDA clearance to market new AEDOpto Circuits surged as much as 14.21 per cent in intraday trade after its group company Cardiac Science Corporation got market clearance.
06 May, 2015, 10.15 AM IST
Lupin gets USFDA approval to market HIV drug; stock upLupin moved higher in trade as the Mumbai-based drug maker got a tentative approval from the USFDA to market Darunavir Ethanolate tablets.
31 Dec, 2014, 09.58 AM IST
- Hot stock: Goldman Sachs sees over 45% upside in Essar Oil
Goldman Sachs has maintained ‘buy’ rating on Essar Oil with a target price of Rs 110, an upside of over 45 per cent from the current market...
05 Mar, 2013, 04.39 PM IST
- Venus Remedies gets Australian patent approval for Vancoplus
Drug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.
10 Apr, 2012, 02.10 PM IST
- Lupin gets tentative USFDA approval for Pregabalin; stk up
Lupin’s subsidiary Lupin Pharmaceuticals Inc has received tentative ANDA approval for its Pregabalin capsules from the USFDA.
07 Jul, 2011, 02.55 PM IST
- Bafna Pharma gets Ghana's approval for hypertension drug
Bafna Pharmaceuticals on Wednesday said it has received Ghana health regulator's approval to sell Atenolol tablets, used in the treatment o...
10 Nov, 2010, 08.24 PM IST